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Escherichia coli O157:H7 infections pose a
serious public health threat (1-4). Surveillance,
rapid reporting of cases, and prompt epidemio-
logic investigations are essential elements of
timely public health response (2,5). Surveillance
that uses molecular subtyping methods has at
least two advantages over traditional surveil-
lance systems (6). First, it is sensitive enough to
identify outbreaks not detected by traditional
surveillance or can detect them earlier. Second, it
is specific enough to differentiate sporadic cases
from outbreak-related cases and distinguish
between single and multiple outbreaks.
A subtype-specific surveillance system con-
sists of 1) mandatory submission of E. coli
O157:H7 isolates for subtyping; 2) a centrally
located laboratory equipped to perform subtyping
by pulsed-field gel electrophoresis; 3) active links
between local and state health officials; and 4)
epidemiologic capacity to investigate the possibil-
ity of an outbreak once identical strains are
identified.
In August 1997, the Colorado Department of
Public Health and Environment, using subtype-
specific surveillance, identified an outbreak
associated with eating hamburgers from beef
processed in a plant in Nebraska and distributed
nationally. After the outbreak was traced to the
contaminated beef, the company recalled 25
million pounds of ground beef, the largest meat
recall recorded (7).
We used cost-benefit analysis to assess the
economic feasibility (from a societal perspective)
of using a system similar to the one in Colorado
for identifying E. coli O157:H7 outbreaks.
The Study
A system is cost-beneficial if the discounted
benefits it generates are at least as great as the
discounted costs of installing and operating the
system. The life span of the subtype-specific
surveillance system in Colorado is 5 years,
yielding benefits over the lifetime of people
affected by it. Data on the costs of the system
were obtained from the Colorado Department of
Public Health and Environment (Table 1). The
system was not set up only to subtype for E. coli
O157:H7 but also to identify outbreaks of other
organisms (e.g., Salmonella typhi); only E. coli-
related costs were considered here. The
sensitivity of the results was examined with all
the costs of the system attributed to E. coli
O157:H7 subtyping.
In estimating the costs of outbreak investiga-
tions, we assumed that, as a result of the system,
two epidemiologic investigations would be
carried out each year, with an average cost of
$9,600 per outbreak (Table 1). The costs
associated with recalling any outbreak-related
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Table 1. Costs of installing and operating the subtype-specific surveillance system, Colorado, 1996
Labor and equipment costs Total costs Escherichia coli-related costsa
Equipment $40,000 $16,000
Laboratory scientist (per year)b $10,000   $4,000
Analyzing the isolates (per year)c $12,000 $12,000
Investigating an outbreakd,e   $9,600   $9,600
Present value of outbreak costs (in 5 years)f $90,568 $90,568
Annual operating costsg $41,200 $35,200
aFrom the proportion of E. coli isolates among the total number of isolates expected to be subtyped each year, we extrapolated
that 40% of the equipment and labor costs were E. coli-related.
bThe salary and fringe benefits of a full-time laboratory analyst.
cAnalyzing 300 isolates at a cost of $40 per isolate.
dThis cost included, but was not limited to, the value of time (15 days) spent investigating an outbreak, answering telephone
calls, conducting meetings, improving and transferring pulsed-field gel electrophoresis image files to various groups, creating
databases, requesting information, responding to media calls, and handling legal issues. We assumed that, as a result of the
system, two outbreaks would be investigated each year (6).
eThe costs of additional labor and the epidemiologic investigation of an outbreak were estimated at $5,000 and $4,600,
respectively.
fAt a discount rate of 3%.
gLaboratory scientist ($10,000) + analyzing the isolates ($12,000) + investigating two outbreaks (2 x $9,600 = $19,200)
product were not included. Data (e.g., percentage
of contaminated beef) that would allow us to
attribute economic value to the amount of the
product recalled were not available. In the
sensitivity analysis, costs were increased by
100% to account for such missing data.
The benefits of the surveillance system are
the economic savings accrued from E. coli
O157:H7 cases averted. Determining the number
of cases averted as a result of using the system is
difficult. One way of determining this number is
by estimating the attack rate and multiplying
that number by the amount of beef recalled (8).
However, for the outbreak in Colorado, data
for estimating specific attack rates were lacking.
Instead, we estimated two threshold numbers of
cases that must be averted for the costs to be
equal to the benefits of the system. The first
threshold number was calculated by assuming
the system averts a constant number of cases
every year. The second number was calculated
under the assumption that the system averts
only a given number of cases in the first year and
no cases in subsequent years. If the estimated
threshold is below a reasonable number, the
system is cost beneficial. A reasonable number is
calculated by consulting the literature and expert
opinion.
The average cost of an E. coli  O157:H7
infection was estimated by using an infection
outcome tree (4) (Figure). A person infected with
E. coli O157:H7 can be in only one disease
severity category (Figure; Table 2). The far-left
branch of the tree is designated as severity
category no. 9. The probability is 0.2% (10%
hospitalization x 50% hemolytic uremic syn-
drome [HUS] x 4% death) that an infected person
will be hospitalized for hemorrhagic colitis, come
down with HUS, and die after 1 year. From the
time of infection until the time of death, the
societal costs for this patient are $991,221
(medical costs $39,204 + productivity losses
$3,041 + lost lifetime earnings $948,976).
Data on the probability of being in any of
these categories were obtained from Roberts et
al. (3). The economic costs associated with each
category were based on the methods and
assumptions of Buzby et al. (4), with modifica-
tions (Table 2). Productivity losses were
estimated by multiplying the average wage in
1996 by the number of days missed from work.
The average wage rate was estimated by using
the average daily earnings of a nonagricultural
nonsupervisory employee, assuming that fringe
benefits are 39% of total wages or salaries and a
labor participation rate of 84% (4). We estimated
the costs of a death by using only the lost lifetime
earnings, as estimated by Haddix et al. (9) and
updated by the rates of change in wages. Because
we did not assess pain and suffering from the
disease or loss of human life, our estimates of
benefits should be considered conservatively low.
All costs and benefits were adjusted to 1996
dollars according to the consumer price index or
its components (various issues of the Statistical
Abstract). All future costs and benefits wereDispatches Dispatches Dispatches Dispatches Dispatches
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Figure. Escherichia coli O157:H7 infection outcome tree. Severity categories (1)-(9) are described in Table 2.
Table 2. Assumptions about disease severity following an Escherichia coli O157:H7 infectiona
Severity
category Assumptions
No. 1 Patient does not seek medical care, recovers, and misses 2 days of work
No. 2 Patient seeks medical care for hemorrhagic colitis, has one laboratory test, recovers, and
misses 4 days of work
No. 3 Patient is hospitalized for hemorrhagic colitis for 6.5 days and recovers after missing 14 days
of work
No. 4 Patient is hospitalized for hemorrhagic colitis for 6.5 days, misses 14 days of work, and dies
in the first year
No. 5 Patient is hospitalized for acute HUSb for 5 days in ICUc and 10 days in a regular room, and
recovers after missing 32 days of work
No. 6 Patient is hospitalized for acute HUSb for 5 days in ICUc and 10 days in a regular room,
requires dialysis for 12 days, and recovers after missing 32 days of work
No. 7 Patient is hospitalized for hemorrhagic colitis; comes down with chronic HUSb; may require
dialysis, transplants, or drug therapy; cannot work for an extended period; and recovers
No. 8 Patient is hospitalized for hemorrhagic colitis; comes down with chronic HUSb; may require
dialysis, transplants, or drug therapy; cannot work for an extended period; and dies
No. 9 Patient is hospitalized for acute HUSb for 5 days in ICUc and 10 days in a regular room and
dies after missing 32 days of work
aAdapted from Buzby et al. (4). A patient is defined as a person infected with E. coli O157:H7 who has at least a gastrointestinal
illness for more than 1 day.
bHUS, hemolytic uremic syndrome.
cICU, intensive care unit.Dispatches Dispatches Dispatches Dispatches Dispatches
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Table 3. Discounted costs of an Escherichia coli O157:H7 infection, discounted costs of the surveillance system, and
threshold number of cases, 1996
Discount ratea
Components affecting costs 3% 0% 5%
Discounted average cost of an E. coli O157:H7 infection     $7,788   $15,927     $5,847
Discounted costs of installing and operating the system $182,042 $192,000 $176,018
Baseline (best estimate)
Cases that need to be averted every year for 5 yearsb              5.0              2.4           6.6
Cases that need to be averted in the first year alonec            14.2              7.2         18.5
One-way sensitivity analysis
Increasing labor and equipment costs from $20,000 to $50,000
Cases that need to be averted every year for 5 yearsb              6.4              3.1           8.6
Cases that need to be averted in the first year alonec            20.9            10.6         27.2
Decreasing the costs of an infection from $7,788 to $3,894
Cases that need to be averted every year for 5 yearsb              9.9              4.8         13.2
Cases that need to be averted in the first year alonec            28.4            14.5         36.9
Increasing the probability of death from 0.4% to 2.3%
Cases that need to be averted every year for 5 yearsb              1.5              0.5           2.6
Cases that need to be averted in the first year alonec              4.3              1.5           7.3
aThe most frequently assumed discount rate is 5%. However, 3% is the recommended rate. No discounting is suggested for
testing the sensitivity of the results (10).
bThreshold number of cases averted every year for 5 years above which the system is cost-beneficial.
cThreshold number of cases averted in the first year above which the system is cost-beneficial, assuming the system does not
avert any cases in subsequent years and continues to incur costs.
discounted at 3%. Other rates were used in the
sensitivity analysis.
The discounted average cost of an E.  coli
O157:H7 infection was $7,788 (Table 3). The
main component of the cost of a case was the
expected cost of sequelae and death. The
undiscounted cost of a case was $15,927. The
discounted cost of installing and operating the
surveillance system over a period of 5 years was
$182,042 (Table 3). Included in this category were
the costs of investigating outbreaks ($90,568 in 5
years), of the subtyping equipment ($16,000), and
of analyzing the isolates ($60,000 in 5 years)
(Table 1). At a 3% discount, five cases per year (or
14 cases in the first year only) must be averted for
the costs of the system to be equal to its benefits
(Table 3). Without discounting, the threshold
number dropped to 2.4 cases per year (Table 3).
Sensitivity Analysis
The estimated costs of a case were sensitive to the
estimates of the probability of death after
infection. If the probability of death is raised to
2.3% (4), the cost of a case increases to $25,997,
and the threshold number of cases averted for the
system to be economically feasible decreases to
1.5 per year for 5 years, or 4.3 cases in the first
year and none in the following years (Table 3).
If all the costs of subtyping (including
subtyping for other organisms) were included in
the analysis, the system would recover its costs
after averting 6.4 infections annually, or 20.9
cases in the first year only, with no cases detected
in subsequent years. If the costs of the system
doubled or the benefits of a case averted
decreased by 50%, the threshold number would
increase to 9.9 cases per year, or 28.4 cases in the
first year only (Table 3). Doubling the number of
outbreaks or considering only direct medical
costs would raise the threshold numbers to 7.4
and 11.4 cases per year, respectively.
Conclusions
If 15 cases were averted by the recall of the 25
million pounds of potentially contaminated beef,
the Colorado system would have recovered all
costs for the 5 years of start-up and operation by
detecting a single outbreak (Table 3). In
comparison, the outbreak-related 1993 recall of
255,000 regular (0.1-lb) hamburgers in Washing-
ton State was estimated to have prevented 800
cases (8).
The discounted average cost of an E. coli
O157:H7 infection of $7,788 (Table 3) was a
relatively conservative estimate compared
with that of $38,000 (in 1995 dollars) by Buzby
et al. (4). The major differences are the
probability of death and the economic value of life
used in the estimation (11).
If other benefits of the system (e.g., obviating
the need to investigate sporadic cases) are
included, the system becomes even more costDispatches Dispatches Dispatches Dispatches Dispatches
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beneficial. Unproductive extensive traceback
investigations of sporadic E. coli O157:H7
infections have been conducted (12). Investi-
gating such sporadic cases can be very costly
(Table 1), and a subtype-specific system can
reduce such costs.
According to the National Electronic Tele-
communications System for Surveillance, 90
cases of E.  coli  O157:H7 were reported in
Colorado in 1998 (13), an annual incidence rate
of 2.3 per 100,000 population. In comparison,
the national incidence rate calculated from
these data was 1.2 per 100,000 population
(3,161 cases).
This study was limited by lack of data that
would have enabled us to estimate attack rates
from the outbreak, cases averted by the meat
recall, and the benefit to society (money saved) by
establishing the system. Despite its limitations,
this study has important implications for public
health policy. From a societal perspective, a
surveillance system does not need to prevent a
large number of cases to yield return on the
resources invested in it.
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